Hydrogen sulfide ameliorates homocysteine-induced cardiac remodeling and dysfunction

Sumit Kar, Hamid R. Shahshahan, Tyler N. Kambis, Santosh K. Yadav, Zhen Li, David J. Lefer, Paras K. Mishra

Research output: Contribution to journalArticle

Abstract

Patients with diabetes, a methionine-rich meat diet, or certain genetic polymorphisms show elevated levels of homocysteine (Hcy), which is strongly associated with the development of cardiovascular disease including diabetic cardiomyopathy. However, reducing Hcy levels with folate shows no beneficial cardiac effects. We have previously shown that a hydrogen sulfide (H2S), a by-product of Hcy through transsulfuration by cystathionine beta synthase (CBS), donor mitigates Hcy-induced hypertrophy in cardiomyocytes. However, the in vivo cardiac effects of H2S in the context of hyperhomocysteinemia (HHcy) have not been studied. We tested the hypothesis that HHcy causes cardiac remodeling and dysfunction in vivo, which is ameliorated by H2S. Twelve-week-old male CBS+/− (a model of HHcy) and sibling CBS+/+ (WT) mice were treated with SG1002 (a slow release H2S donor) diet for 4 months. The left ventricle of CBS+/− mice showed increased expression of early remodeling signals c-Jun and c-Fos, increased interstitial collagen deposition, and increased cellular hypertrophy. Notably, SG1002 treatment slightly reduced c-Jun and c-Fos expression, decreased interstitial fibrosis, and reduced cellular hypertrophy. Pressure volume loop analyses in CBS+/− mice revealed increased end systolic pressure with no change in stroke volume (SV) suggesting increased afterload, which was abolished by SG1002 treatment. Additionally, SG1002 treatment increased end-diastolic volume and SV in CBS+/− mice, suggesting increased ventricular filling. These results demonstrate SG1002 treatment alleviates cardiac remodeling and afterload in HHcy mice. H2S may be cardioprotective in conditions where H2S is reduced and Hcy is elevated.

Original languageEnglish (US)
Article number598
JournalFrontiers in Physiology
Volume10
Issue numberMAY
DOIs
StatePublished - Jan 1 2019

Fingerprint

Cystathionine beta-Synthase
Hydrogen Sulfide
Homocysteine
Hyperhomocysteinemia
Hypertrophy
Stroke Volume
Tissue Donors
Diabetic Cardiomyopathies
Diet
Genetic Polymorphisms
Therapeutics
Folic Acid
Cardiac Myocytes
Methionine
Meat
Heart Ventricles
Siblings
Fibrosis
Cardiovascular Diseases
Collagen

Keywords

  • Cardioprotection
  • Fibrosis
  • H2S
  • Hyperhomocysteinemia
  • Hypertrophy

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Hydrogen sulfide ameliorates homocysteine-induced cardiac remodeling and dysfunction. / Kar, Sumit; Shahshahan, Hamid R.; Kambis, Tyler N.; Yadav, Santosh K.; Li, Zhen; Lefer, David J.; Mishra, Paras K.

In: Frontiers in Physiology, Vol. 10, No. MAY, 598, 01.01.2019.

Research output: Contribution to journalArticle

Kar, Sumit ; Shahshahan, Hamid R. ; Kambis, Tyler N. ; Yadav, Santosh K. ; Li, Zhen ; Lefer, David J. ; Mishra, Paras K. / Hydrogen sulfide ameliorates homocysteine-induced cardiac remodeling and dysfunction. In: Frontiers in Physiology. 2019 ; Vol. 10, No. MAY.
@article{f87a5d4022fd465da97ac30665809a81,
title = "Hydrogen sulfide ameliorates homocysteine-induced cardiac remodeling and dysfunction",
abstract = "Patients with diabetes, a methionine-rich meat diet, or certain genetic polymorphisms show elevated levels of homocysteine (Hcy), which is strongly associated with the development of cardiovascular disease including diabetic cardiomyopathy. However, reducing Hcy levels with folate shows no beneficial cardiac effects. We have previously shown that a hydrogen sulfide (H2S), a by-product of Hcy through transsulfuration by cystathionine beta synthase (CBS), donor mitigates Hcy-induced hypertrophy in cardiomyocytes. However, the in vivo cardiac effects of H2S in the context of hyperhomocysteinemia (HHcy) have not been studied. We tested the hypothesis that HHcy causes cardiac remodeling and dysfunction in vivo, which is ameliorated by H2S. Twelve-week-old male CBS+/− (a model of HHcy) and sibling CBS+/+ (WT) mice were treated with SG1002 (a slow release H2S donor) diet for 4 months. The left ventricle of CBS+/− mice showed increased expression of early remodeling signals c-Jun and c-Fos, increased interstitial collagen deposition, and increased cellular hypertrophy. Notably, SG1002 treatment slightly reduced c-Jun and c-Fos expression, decreased interstitial fibrosis, and reduced cellular hypertrophy. Pressure volume loop analyses in CBS+/− mice revealed increased end systolic pressure with no change in stroke volume (SV) suggesting increased afterload, which was abolished by SG1002 treatment. Additionally, SG1002 treatment increased end-diastolic volume and SV in CBS+/− mice, suggesting increased ventricular filling. These results demonstrate SG1002 treatment alleviates cardiac remodeling and afterload in HHcy mice. H2S may be cardioprotective in conditions where H2S is reduced and Hcy is elevated.",
keywords = "Cardioprotection, Fibrosis, H2S, Hyperhomocysteinemia, Hypertrophy",
author = "Sumit Kar and Shahshahan, {Hamid R.} and Kambis, {Tyler N.} and Yadav, {Santosh K.} and Zhen Li and Lefer, {David J.} and Mishra, {Paras K.}",
year = "2019",
month = "1",
day = "1",
doi = "10.3389/fphys.2019.00598",
language = "English (US)",
volume = "10",
journal = "Frontiers in Physiology",
issn = "1664-042X",
publisher = "Frontiers Research Foundation",
number = "MAY",

}

TY - JOUR

T1 - Hydrogen sulfide ameliorates homocysteine-induced cardiac remodeling and dysfunction

AU - Kar, Sumit

AU - Shahshahan, Hamid R.

AU - Kambis, Tyler N.

AU - Yadav, Santosh K.

AU - Li, Zhen

AU - Lefer, David J.

AU - Mishra, Paras K.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Patients with diabetes, a methionine-rich meat diet, or certain genetic polymorphisms show elevated levels of homocysteine (Hcy), which is strongly associated with the development of cardiovascular disease including diabetic cardiomyopathy. However, reducing Hcy levels with folate shows no beneficial cardiac effects. We have previously shown that a hydrogen sulfide (H2S), a by-product of Hcy through transsulfuration by cystathionine beta synthase (CBS), donor mitigates Hcy-induced hypertrophy in cardiomyocytes. However, the in vivo cardiac effects of H2S in the context of hyperhomocysteinemia (HHcy) have not been studied. We tested the hypothesis that HHcy causes cardiac remodeling and dysfunction in vivo, which is ameliorated by H2S. Twelve-week-old male CBS+/− (a model of HHcy) and sibling CBS+/+ (WT) mice were treated with SG1002 (a slow release H2S donor) diet for 4 months. The left ventricle of CBS+/− mice showed increased expression of early remodeling signals c-Jun and c-Fos, increased interstitial collagen deposition, and increased cellular hypertrophy. Notably, SG1002 treatment slightly reduced c-Jun and c-Fos expression, decreased interstitial fibrosis, and reduced cellular hypertrophy. Pressure volume loop analyses in CBS+/− mice revealed increased end systolic pressure with no change in stroke volume (SV) suggesting increased afterload, which was abolished by SG1002 treatment. Additionally, SG1002 treatment increased end-diastolic volume and SV in CBS+/− mice, suggesting increased ventricular filling. These results demonstrate SG1002 treatment alleviates cardiac remodeling and afterload in HHcy mice. H2S may be cardioprotective in conditions where H2S is reduced and Hcy is elevated.

AB - Patients with diabetes, a methionine-rich meat diet, or certain genetic polymorphisms show elevated levels of homocysteine (Hcy), which is strongly associated with the development of cardiovascular disease including diabetic cardiomyopathy. However, reducing Hcy levels with folate shows no beneficial cardiac effects. We have previously shown that a hydrogen sulfide (H2S), a by-product of Hcy through transsulfuration by cystathionine beta synthase (CBS), donor mitigates Hcy-induced hypertrophy in cardiomyocytes. However, the in vivo cardiac effects of H2S in the context of hyperhomocysteinemia (HHcy) have not been studied. We tested the hypothesis that HHcy causes cardiac remodeling and dysfunction in vivo, which is ameliorated by H2S. Twelve-week-old male CBS+/− (a model of HHcy) and sibling CBS+/+ (WT) mice were treated with SG1002 (a slow release H2S donor) diet for 4 months. The left ventricle of CBS+/− mice showed increased expression of early remodeling signals c-Jun and c-Fos, increased interstitial collagen deposition, and increased cellular hypertrophy. Notably, SG1002 treatment slightly reduced c-Jun and c-Fos expression, decreased interstitial fibrosis, and reduced cellular hypertrophy. Pressure volume loop analyses in CBS+/− mice revealed increased end systolic pressure with no change in stroke volume (SV) suggesting increased afterload, which was abolished by SG1002 treatment. Additionally, SG1002 treatment increased end-diastolic volume and SV in CBS+/− mice, suggesting increased ventricular filling. These results demonstrate SG1002 treatment alleviates cardiac remodeling and afterload in HHcy mice. H2S may be cardioprotective in conditions where H2S is reduced and Hcy is elevated.

KW - Cardioprotection

KW - Fibrosis

KW - H2S

KW - Hyperhomocysteinemia

KW - Hypertrophy

UR - http://www.scopus.com/inward/record.url?scp=85068203975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068203975&partnerID=8YFLogxK

U2 - 10.3389/fphys.2019.00598

DO - 10.3389/fphys.2019.00598

M3 - Article

C2 - 31178749

AN - SCOPUS:85068203975

VL - 10

JO - Frontiers in Physiology

JF - Frontiers in Physiology

SN - 1664-042X

IS - MAY

M1 - 598

ER -